Project Grant T32TR005739
- The National Center for Advancing Translational Sciences at the National Institutes of Health awarded Georgetown University $181,747 on August 7, 2026, under the NCATS program (CFDA 93.350) to support a predoctoral training program in translational biomedical science. Georgetown University, in partnership with Howard University, MedStar Health Research Institute, the Washington DC Veterans Administration Medical Center, and Oak Ridge National Laboratory, operates the Georgetown-Howard...
- The National Center for Advancing Translational Sciences awarded a cooperative agreement to Georgetown University for $3.969 million on August 4, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350). Georgetown University leads the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS), a multi-institutional partnership that includes Howard University, MedStar Health Research Institute, the Washington DC Veterans...
- The National Center for Advancing Translational Sciences awarded Georgetown University $752,548 on September 1, 2026, under the CTSA K12 Program (CFDA 93.350) to support clinical and translational science training and career development for early-stage investigators. Georgetown University operates the K12 program as part of the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS), a partnership that includes Howard University, MedStar Health Research...
- The National Center for Advancing Translational Sciences awarded Johns Hopkins University $1,644,144 on September 15, 2025, under the CTSA Postdoctoral T32 program (CFDA 93.350) to operate an integrated postdoctoral training program in clinical and translational research through August 31, 2030. The program delivers mentored training in translational science core principles, biodesign methodology and research applications, and community engagement skills to postdoctoral trainees. The...
- The National Center for Advancing Translational Sciences (NCATS) at the National Institutes of Health awarded New York University $462,079 on September 1, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350) to support a postdoctoral training program in translational science. The NYU CTSI T32 Postdoctoral Training Program equips postdoctoral scholars with knowledge, skills, and abilities to lead interdisciplinary teams spanning pre-clinical research,...
- The National Institutes of Health National Center for Advancing Translational Sciences awarded the University of Pennsylvania $532,701 on July 6, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350) to support a postdoctoral training program in clinical and translational science. The award funds the CTSA Postdoctoral T32 at Penn, which trains clinical and translational science investigators to move scientific discoveries from the laboratory into clinical...
- The National Center for Advancing Translational Sciences, a division of the National Institutes of Health, awarded The Ohio State University $510,909 under Project Grant T32TR005761 on September 17, 2025, to establish and operate a postdoctoral training program in clinical and translational data science. The program recruits and trains postdoctoral fellows across multiple disciplinary backgrounds in clinical and translational data science, with four thematic areas: artificial intelligence in...
- The National Center for Advancing Translational Sciences awarded the University of Pittsburgh $502,465 on August 1, 2026, under the National Center for Advancing Translational Sciences program (CFDA 93.350) to support a postdoctoral T32 training initiative in clinical and translational research. The award funds the University of Pittsburgh Institute for Clinical Research Education (ICRE) to deliver comprehensive postdoctoral fellowship training and career development programs designed to equip...
- The National Center for Advancing Translational Sciences awarded the University of Massachusetts Medical School $328,040 on August 15, 2026, under the CTSA Predoctoral T32 training program (Assistance Listing 93.350) to develop a two-year predoctoral training program in clinical and translational science. The program will recruit three cohorts of six doctoral students with guaranteed funding across rigorous doctoral programs in nursing, MD/PhD, population health sciences, epidemiology,...
- The National Center for Advancing Translational Sciences at the National Institutes of Health awarded a cooperative agreement to New York University on March 20, 2026, obligating $38.325 million under CFDA 93.350 (National Center for Advancing Translational Sciences). The award funds the New York University Clinical and Translational Science Institute (CTSI) hub, which will enhance community-engaged research, democratize health informatics resources, develop a well-rounded translational...
The National Center for Advancing Translational Sciences at the National Institutes of Health awarded Georgetown University $206,908 on September 1, 2026, under the CTSA Postdoctoral T32 Program (CFDA 93.350) to support a two-year translational biomedical science training program for postdoctoral fellows. Georgetown University leads the Georgetown-Howard Universities Center for Clinical and Translational Sciences (GHUCCTS), a multi-institutional partnership also comprising Howard University, MedStar Health Research Institute, the Washington DC Veterans Administration Medical Center, and Oak Ridge National Laboratory. The award funds postdoctoral training in clinical and translational research skills for fellows recruited from Georgetown University, Howard University, MedStar Health Research Institute, and the DC VA Medical Center. The program builds on a ten-year track record: prior cohorts of 24 postdoctoral alumni produced 141 publications (55 as first author), 74 talks, 112 poster presentations, and 26 extramural grants, with 96 percent remaining in clinical and translational research and related fields. Performance occurs in Washington, DC. The award period runs through August 31, 2031. As a Project Grant under the National Center for Advancing Translational Sciences' mission to accelerate the translational research pipeline and speed delivery of new diagnostics and therapeutics to patients, the funding supports workforce development in translational biomedical science within the GHUCCTS partnership network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $206.9k | 8/19/26 |